Sweet's syndrome associated with granulocyte colony-stimulating factor

K K Jain

Sweet's syndrome associated with granulocyte colony-stimulating factor

Cutis. 1996 Feb;57(2):107-10.

Author

K K Jain¹

Affiliation

¹ Drug Safety Department, Hoffmann La Roche Ltd., Basel, Switzerland.

PMID: 8646854

Abstract

Sweet's syndrome has been reported to occur in patients with malignant and inflammatory diseases. It may occur as an adverse reaction to the use of drugs, particularly the recombinant human granulocyte colony-stimulating factor (Filgrastim).

Publication types

Review

MeSH terms

Filgrastim
Granulocyte Colony-Stimulating Factor / adverse effects*
Humans
Neutropenia / therapy
Recombinant Proteins / adverse effects
Sweet Syndrome / etiology*

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Filgrastim